Health Care: Drugs

Dendreon Corp (DNDN: NASDAQ)

$1.13 n/a | n/a%
10/20/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 1.14
52 Week High 3.52
52 Week Low 0.89
Avg. Daily Vol. (Mil) 2.37
Beta (3 year) 2.92
Share Related Items
Mkt Cap (Mil) 182.76
Shares Out (Mil) 160.31
Float (Mil) 156.68
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.10
Current Ratio 3.20
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.62
Price/Book 0.00
Price/Cash Flow -1.20
Per Share Data
Earnings -1.36
Sales 1.83
Book Value 0.00
Cash Flow -0.93
Business Summary
Dendreon Corp is a biotechnology company. The Company is engaged in the discovery, development and commercialization of novel therapeutics that improve cancer treatment options for patients.
General Information
1301 2nd Avenue
Seattle, WA 98101
Industry : Drugs
Sector: Health Care
Employees: 710
CEO: W. Thomas Amick
Short Interest
Current Month (Mil) 29.08
Previous Month (Mil) 39.79
Short Interest Ratio (Days) 13.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -56.90
Return on Investments -72.80
Gross Margin 67.80
EBIT Margin -52.30
Profit Margin -70.70

Portfolios with DNDN

Latest DNDN Headlines from TheStreet

More Financial News for DNDN

Press Releases for DNDN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter